Author Correction: Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer (Nature Communications, (2023), 14, 1, (3357), 10.1038/s41467-023-38887-7)

Thanh Nguyen, Dhivya Sridaran, Surbhi Chouhan, Cody Weimholt, Audrey Wilson, Jingqin Luo, Tiandao Li, John Koomen, Bin Fang, Nagireddy Putluri, Arun Sreekumar, Felix Y. Feng, Kiran Mahajan, Nupam P. Mahajan

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

Correction to: Nature Communications, published online 09 June 2023 This Article omits a declaration from the Competing Interests statement, which should have included the following: ‘A patent “Inhibitors of ACK1/TNK2 Tyrosine Kinase” (patent no. 9,850,216; 10,017,478 and 10,336,734) covers (R)-9b compound. NPM and KM are named as inventors. These patents have been licensed by TechnoGenesys Inc. KM and NPM are co-founders of TechnoGenesys Inc., own stocks, and serve as consultants for TechnoGenesys Inc. The other authors declare no potential conflicts of interest.’ These errors have now been corrected in either the PDF or HTML versions of the article.

Original languageEnglish
Article number6022
JournalNature communications
Volume14
Issue number1
DOIs
StatePublished - Dec 2023

Fingerprint

Dive into the research topics of 'Author Correction: Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer (Nature Communications, (2023), 14, 1, (3357), 10.1038/s41467-023-38887-7)'. Together they form a unique fingerprint.

Cite this